Patent Assignment
Reel/Frame 012418/0730
Security Agreement
Recorded: 2002-01-09
Pages: 49
Assignor
IMMINE RESPONSE CORPORATION, THE
Executed: 2001-11-09
Assignee
KEVIN KIMBERLIN PARTNERS, L.P.
535 MADISON AVENUE, NEW YORK, NEW YORK, 10022
Covered Properties
(35)
Whip Tilt Adapter
Patent:
5,144,326 →
Application:
07/612,384 →
Retroviral Antigens
Patent:
5,256,767 →
Application:
07/975,899 →
Vaccination and Methods Against Multiple Sclerosis Resulting from Pathogenic Responses by Specific T Cell Populations
Patent:
6,464,978 →
Application:
08/055,006 →
T Cell Receptor Peptides as Therapeutics for Immune-Related Disease
Patent:
5,614,192 →
Application:
08/059,020 →
Vaccination Against Diseases Resulting from Pathogenic Responses by Specific T Cell Populations
Patent:
5,612,035 →
Application:
08/103,418 →
Vaccination Against Diseases Resulting from Pathogenic Responses by Specific T Cell Populations
Patent:
5,861,164 →
Application:
08/146,454 →
Peptides and Methods Against Psoriasis
Patent:
6,413,516 →
Application:
08/182,967 →
Prevention and Treatment of Retroviral Disease
Patent:
5,853,725 →
Application:
08/233,508 →
Vaccination and Methods Against Diseases Resulting from Pathogenic Responses by Specific T Cell Populations
Patent:
6,207,645 →
Application:
08/276,776 →
Anti-Idiotype Vaccination Against Diseases Resulting from Pathogenic Responses by Specific T Cell Populations
Patent:
6,007,815 →
Application:
08/332,428 →
Vaccination and Methods Against Diseases Resulting from Pathogenic Responses by Specific T Cell Populations
Patent:
5,837,246 →
Application:
08/376,049 →
Prevention and Treatment of Retroviral Disease
Patent:
5,928,930 →
Application:
08/464,137 →
Prevention and Treatment of Retroviral Disease
Patent:
5,916,806 →
Application:
08/464,139 →
Vaccination and Methods Against Diseases Resulting from Pathogenic Responses by Specific T Cell Populations
Patent:
6,159,470 →
Application:
08/464,506 →
Vaccination and Methods Against Diseases Resulting from Pathogenic Responses by Specific T Cell Populations
Patent:
5,985,552 →
Application:
08/466,860 →
Prevention and Treatment of Retroviral Disease
Patent:
6,017,543 →
Application:
08/467,302 →
Prevention and Treament of Retroviral Disease
Patent:
5,895,650 →
Application:
08/467,334 →
Prevention and Treatment of Retroviral Disease
Patent:
5,885,578 →
Application:
08/469,739 →
Vaccination and Methods Against Diseases Resulting from Pathogenic Responses by Specific T Cell Populations
Patent:
6,221,352 →
Application:
08/471,209 →
Vaccination and Methods Against Diseases Resulting from Pathogenic Responses
Patent:
6,090,387 →
Application:
08/472,040 →
Tcr V Beta 5 Peptides
Patent:
5,776,459 →
Application:
08/476,405 →
Method of Preparing Polynucleotide-Carrier Complexes for Delivery to Cells
Patent:
5,994,316 →
Application:
08/604,306 →
Antisense Constructs Directed Against Viral Post-Transcriptional Regulatory Sequences
Patent:
5,843,770 →
Application:
08/613,861 →
Production and Purification of Retroviral Particles Using Tentacle Anion Exchange
Patent:
5,661,023 →
Application:
08/613,920 →
Targeted Delivery of Genes Encoding Interferon
Patent:
6,069,133 →
Application:
08/819,238 →
Highly Efficient Production and Isolation of Viral Particles Utilizing Tentacle Anion Exchange
Patent:
6,080,571 →
Application:
08/842,702 →
Membrane-Bound Cytokine Compositions Comprising Gm=Csf and Methods of Modulating an Immune Response Using Same
Patent:
5,891,432 →
Application:
08/902,516 →
Membrane-Bound Cytokine Compositions and Methods of Modulating an Immune Response Using Same
Application:
09/201,931 →
Novel Vectors and Genes Exhibiting Increased Expression
Patent:
6,642,028 →
Application:
09/205,817 →
Targeted Delivery of Genes Encoding Interferon
Patent:
6,331,525 →
Application:
09/379,434 →
Novel vectors and genes exhibiting increased expression
Application:
09/553,368 →
Genetically engineered tumor cell vaccines
Application:
09/772,102 →
Publication:
US 2002/0006413
Membrane-Bound Cytokine Compositions Comprising Gm-Csf or an Active Fragment Thereof and Methods of Modulating an Immune Response Using Same
Methods of identifying and monitoring disease-associated T cells
Application:
09/853,830 →
Publication:
US 2002/0107388
Methods for treating HIV-infected individuals
Application:
60/264,476 →
Related Assignments
(1)
Other recorded transfers of the patents in this record — the chain of ownership.